BRCA2 and breast cancer: As it has now been established that LOF variants in PALB2 convey a similarly high risk for breast cancer as BRCA2 LOF variants (Antoniou et al., 2003, 2014; Couch et al., 2017), PALB2 has become widely included in breast cancer clinical genetics practice.